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Abstract

The Effects of Vascular Endothelial Growth Factor on the Characteristics of
Pluripotent Dental Pulp Stem Cells

By

Cale Forgues

Dr. Karl Kingsley, Examination Committee Chair
Associate Professor of Biomedical Sciences
Director of Student Research
University of Nevada, Las Vegas
School of Dental Medicine

Many believe that stem cells hold the key to regenerative medicine. Therefore, research
with stem cells has become increasingly popular over the years. Three specific groups of study
have become present in literature. The first group has focused much of their research on
harvesting and cultivating stem cell lines to retain their pluripotent ability. Stem cells can be
tricky to cultivate and preserve over time as they will often differentiate or die. Another group
examines the specific characteristics that a pluripotent stem cell has and how to retain, or even
create, a cell with pluripotent potential. Lastly, the third group aims to focus on the ability to
differentiate stem cells down specific cell lineages for therapeutic use. This study will draw upon
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the latter two focuses and examine the specific characteristics of stem cells when combined with
a cytokine during cultivation.
Vascular endothelial growth factors (VEGF) are a family of growth factors known to play
an important part in embryonic development of vascular formation as well as dental
development. The processes of neovascularization, formation of new vessels in adults, is highly
reliant on the presence of VEGF for both the activation and attraction of undifferentiated bone
marrow derived mesenchymal stem cells (MSCs). While this is the case with bone marrow
derived MSCs, few studies have shown the effects VEGF has on other adult stem cell lines, such
as dental pulp stem cells (DPSC).
Dental pulp stem cells have only recently been discovered. Another source for pluripotent
stem cells, DPSCs are easily harvested from avulsed or extracted teeth. Further studies hope to
determine the versatility of DPSCs and find specific uses for them in regenerative therapies.
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Chapter 1: Introduction
Background and Significance
Having been only recently been discovered, dental pulp stem cells (DPSCs) may have the
potential to revolutionize oral regenerative therapies. Dental pulp stem cells (DPSCs) are nonembryonic, mesenchymal stem cells that are easily harvested, cultured, and maintained from
extracted or avulsed teeth[1-3] For these reason DPSCs are ideal for studying the effects of
growth factors on undifferentiated pluripotent cell lines. Being a stem cell with the ability to
differentiation down any of the major embryonic stem cell lines, current studies are trying to
determine which growth factors can be used to induce differentiation towards a desired cell
lines.[4-5] One of these major growth factors known to be important to embryonic stem cell
attraction and activation is vascular endothelial growth factor (VEGF).
Vascular endothelial growth factor (VEGF) is a family of growth factors known to play
an important part in vascular formation in early endothelial development as well as bone
formation in dental development. [6-7] The majority of studies to date have examined how the
family of VEGF ligands act on specific tyrosine kinase receptors to create intracellular responses
in differentiated endothelial cells. The cellular responses, and intracellular effects of, VEGF on
various lineages of multipotent DPSCs remains relatively unknown.[8-9]
Research Question
Based upon the limited amount of information regarding DPSC and in vitro
differentiation, as well as the limited information regarding VEGF and the potential to
differentiate DPSC – the main objective of this study was to screen evaluate the effects of VEGF
on several DPSC isolates.
1

1. Is there an effect on characteristics of the DPSC lines when cultured with VEGF?
Null (H0) hypothesis: There will be no effect on the characteristics of the DPSC isolates
when cultured with VEGF
Alternative (HA) hypothesis: There will be an effect on the characteristics of the DPSC
isolates when cultured with VEGF

2. Is there an effect on characteristics of the DPSC lines when cultured with VEGF in
combination with BMP-2?
Null (H0) hypothesis: There will be no effect on the characteristics of the DPSC isolates
when cultured with VEGF in combination with BMP-2
Alternative (HA) hypothesis: There will be an effect on the characteristics of the DPSC
isolates when cultured with VEGF in combination with BMP-2
Approval
The protocol for this study was reviewed and approved by the Office for the Protection of
Research Subjects (OPRS) and Institutional Review Board (IRB) OPRS#763012-1
“Retrospective analysis of dental pulp stem cells (DPSC) from the University of Nevada Las
Vegas (UNLV) School of Dental Medicine (SDM) pediatric and adult clinical population”. The
original protocol for the collection and isolation of DPSC was approved by the IRB and
OPRS#0907-3148 “Isolation of Non-Embryonic Stem Cells from Dental Pulp”.
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Research Design
This retrospective study would involve the analysis of DPSCs previously isolated from
clinical patients, recruited at random in the UNLV-SDM pediatric clinic. Eight cell lines will be
used and replicated for three experimental trials (n=24). Cells will be cultured and propagated for
ten passages to determine the rate of growth and doubling time (DT). Doubling time (DT) will be
categorized as rapid or rDT (~2 days), intermediate or iDT (4-6 days), and slow or sDT (10-12
days). To assess any changes to differentiation, total RNA will be isolated from each isolate
using the Total RNA isolation reagent (TRIR) from Molecular Research Center (Cincinnati, OH)
using the protocol recommended by the manufacturer. Screening for changes to mRNA
expression in each DPSC isolated will be accomplished using the ABgene Reverse-iT One-Step
RT-PCR protocol and reagent kit. Comparisons of the changes to viability or proliferation will
be calculated and compared using two-tailed t-tests, which are appropriate for parametric data
analysis. Due to the potential for Type I error, all analyses will be subsequently confirmed using
analysis of variance or multiple (ANOVA).
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Chapter 2
Effects of vascular endothelial growth factor (VEGF) on dental pulp stem cells (DPSC)
This chapter has been submitted for review and publication in the journal Current Research in
Medicine and is presented in the style of that Journal. The complete Citation is:
Forgues C, Kingsley K. Effects of vascular endothelial growth factor (VEGF) on dental pulp
stem cells (DPSC). Journal of Current Research in Medicine
Role of Authors:
This work was carried out in collaboration between all authors. Author Cale Forgues and Eric
Mullins were responsible for sample processing. Authors Dr. Karl Kingsley and Dr. Cale
Forgues were responsible for project design, funding and manuscript preparation. All authors
read and approved the final manuscript.

Abstract
Background: Dental pulp stem cells (DPSCs) are non-embryonic, mesenchymal stem
cells that may have significant potential for therapeutic and regenerative biomedical applications.
Studies of DPSC differentiation have demonstrated the potential to form many tissue types,
including neural, osteogenic, and vascular precursors using cytokines and growth factors, such as
vascular endothelial growth factor (VEGF). Methods: Eight previously isolated dental pulp stem
cell (DPSC) isolates were grown in culture and treated with VEGF to evaluate any effects on
growth, viability or biomarker expression. Results: Administration of VEGF at 10 ng/mL
significantly inhibited growth in two rapidly dividing or rDT DPSC isolates, with no other
measurable effects noted among the intermediate (iDT) or slow (sDT) growing DPSC isolates. In
addition, VEGF administration of had no significant effects on viability of the sDT or iDT DPSC
isolates, however, all three of the rapidly dividing or rDT DPSC isolates exhibited significantly
increased viability. Finally, mRNA expression of osteogenic biomarkers alkaline phosphatase
6

(ALP) and Dentin sialophosphoprotein (DSPP) was observed among the rDT isolates with
specific combinations of DPSC biomarkers expressed (NANOG in combination with Sox-2 or
Oct-4 but not both). Conclusions: The results of these data suggest that VEGF administration
may be sufficient to induce partial differentiation of DPSC isolates, although this may be
dependent upon the MSC biomarker expression of the DPSCs. These preliminary data may
further research into the potential for tissue regeneration and bioengineering.

Key words: Dental pulp stem cell (DPSC), vascular endothelial growth factor (VEGF), cellular
differentiation
Introduction
Dental pulp stem cells (DPSCs) are non-embryonic, mesenchymal stem cells than can be
obtained, isolated, cultured, and cryopreserved with relative ease compared with other potential
sources, which has driven recent scientific research into their potential for therapeutic
applications [1-3]. Harvested from the dental pulp of primary teeth, extracted teeth, or avulsed
teeth, DPSCs are multi-potent stem cells that may be useful to facilitate advanced regenerative
therapies [4,5]. , These studies have provided a better overall understanding of the capabilities of
mesenchymal stem cells (MSCs) and DPSCs, with recent evidence demonstrating that
differentiation potential may depend, in part, on the tissue of origin used in MSC harvesting [68].
Studies done on DPSC differentiation have demonstrated the potential to form many
tissue types, including neural, osteogenic, and vascular precursors [9-11]. Much progress has
been made towards the in vitro and in vivo differentiation of DPSC towards specific cell lineages
[12,13]. In fact, some evidence now suggests that individual growth factors, such as vascular
7

endothelial growth factor (VEGF), may be sufficient to induce partial differentiation of DPSC –
although this may be more dependent upon specific biomarkers or DPSC characteristics [14-16].
It has been demonstrated that DPSCs can be stimulated using VEGF through the
canonical Wnt-β-catenin pathway into differentiating into blood vessels that resembled
embryonic vasculogenesis, revealing the importance of this growth factor (VEGF) in
angiogenesis as well as its potential for regenerative vasculogenesis [11,12,16]. However, the
majority of studies to date have examined how the family of VEGF ligands act on specific
tyrosine kinase receptors to create intracellular responses in differentiated vascular endothelial
cells, while the cellular responses to, and intracellular effects of, VEGF on various lineages of
multipotent DPSCs remain relatively unknown [17].
Differentiation potential and stem-ness may be linked with specific intracellular MSC
biomarkers such as the expression of Sox-2, Oct-4 and NANOG, which have been found to be
highly associated with the pluripotency of cells, including DPSC [18-20]. The presence or
absence of these biomarkers in cultured DPSCs may determine the ability of the isolates to
differentiate and self-replicate [21-23]. Based upon this understanding, the primary objective of
this study was to evaluate the effects of VEGF on several DPSC isolates and to further evaluate
the expression of specific biomarkers that may indicate pluripotency, as well as differentiation.
Methodology
Study approval
The protocol for this study was reviewed and approved by the Office for the Protection of
Research Subjects (OPRS) and Institutional Review Board (IRB) OPRS#763012-1
“Retrospective analysis of dental pulp stem cells (DPSC) from the University of Nevada Las
Vegas (UNLV) School of Dental Medicine (SDM) pediatric and adult clinical population”. The
8

original protocol for the collection and isolation of DPSC was approved by the IRB and
OPRS#0907-3148 “Isolation of Non-Embryonic Stem Cells from Dental Pulp”.

Study Design
This retrospective study involved the analysis of DPSCs previously isolated from clinical
patients, recruited at random the UNLV-SDM pediatric clinic. Inclusion criteria included adult
patients or pediatric patients aged seven (7) or older with their parents or guardian’s permission
who agreed to participate and were scheduled for a tooth extraction of health (vital) intact teeth
prior to the initiation of orthodontic treatment. Pediatric assent and Parental permission to
consent for voluntary participation were obtained at the time of study enrollment. Exclusion
criteria included any patient, parent or child that was not a patient of record at UNLV-SDM, any
patient or guardian who declined to participate and any patients having teeth extracted due to
injury (fracture), infection or other disease.

DPSC Collection (initial)
In brief, the overwhelming majority of patients who agreed to participate were scheduled
for tooth extractions of third molars. Once extracted, each tooth was sectioned at the cementoenamel junction (CEJ) to allow extraction of the dental pulp with an endodontic broach for
transfer into a sterile microcentrifuge tube containing 1X phosphate-buffered saline (PBS).
Samples were stored on ice until transfer to a biomedical laboratory for processing and
screening. To prevent research bias and prevent any patient identifying information from being
disclosed, a randomly generated, non-duplicated number was assigned to each sample and
concurrent patient demographic information collected. No patient-specific identifying
information was subsequently available to any research team member.
9

Culture and Propagation
Briefly, cells were cultured and propagated for ten passages to determine the rate of
growth and doubling time (DT). Passage (or split) for each DPSC isolate was 1:2 and confluence
determined with trypan blue and BioRad TC20 automated cell counter (Hercules, CA), using the
manufacturer recommended protocol. Data collected included total and live cell number and the
resulting percentage of viable cells for analysis. Doubling time (DT) was categorized as rapid or
rDT (~2 days), intermediate or iDT (4-6 days), and slow or sDT (10-12 days).

Experimental protocol
To determine any effects on DPSCs, the cells were plated into 96-well tissue culture
treated plates at a concentration of 1.2 x 104 cells/mL. Negative (non-treated) control cells were
compared with cells treated with vascular endothelial growth factor (VEGF) from ThermoFisher
Scientific (PCH9394) at a concentration of 10 ng/mL. Eight replicates were performed in each
experiment for all DPSC isolates, which were repeated for a total of three experimental trials
(n=24).

RNA isolation
To assess any changes to differentiation, total RNA was isolated from each isolate using
the Total RNA isolation reagent (TRIR) from Molecular Research Center (Cincinnati, OH) using
the protocol recommended by the manufacturer. RNA was subsequently screened for quality and
quantity using ratio measurements of absorbance at 260 and 280 nm (A260/A280 ratio).
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Polymerase chain reaction (PCR)
Screening for changes to mRNA expression in each DPSC isolated was accomplished
using the ABgene Reverse-iT One-Step RT-PCR protocol and reagent kit with specifications that
included an initial reverse transcription at 47C for 30 minutes, followed by 30 cycles of
denaturation at 95C for 10 minutes, annealing for 30 seconds at the appropriate temperature for
each primer set, and final extension at 60C for one minute. Primers synthesize from Eurofins
MWG Operon (Huntsville, AL) were:

Glyceraldehyde 3-phosphate dehydrogenase (GAPDH); Annealing temperature 67C
Forward primer-GAPDH, ATCTTCCAGGAGCGAGATCC; 20 nt, 55% GC, Tm 66C
Reverse primer-GAPDH, ACCACTGACACGTTGGCAGT; 20 nt, 55% GC, Tm 70C
Optimal temperature T(opt): Lower temperature – 5C = 61C

Alkaline phosphatase (ALP); Annealing temperature: 72C
Forward primer-ALP, CACTGCGGACCATTCCCACGTCTT;24 nt, 58% GC, Tm 74C
Reverse primer- ALP, GCGCCTGGTAGTTGTTGTGAGCAT; 24 nt, 54% GC, Tm 72C
Optimal temperature T(opt): Lower temperature – 5C = 67C

Dentin sialophosphoprotein (DSPP); Annealing temperature: 68C
Forward primer-DSPP, CAACCATAGAGAAAGCAAACGCG;23 nt, 48% GC, Tm 67C
Reverse primer- DSPP, TTTCTGTTGCCACTGCTGGGAC; 22 nt, 55% GC, Tm 70C
Optimal temperature T(opt): Lower temperature – 5C = 62C
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Statistical analysis
Basic proliferation and viability information regarding the DPSC isolated were compiled
and presented using simple descriptive statistics (counts and percentages). Comparisons of
change to viability or proliferation were calculated and compared using two-tailed t-tests, which
are appropriate for parametric data analysis. Due to the potential for Type I error, all analyses
were subsequently confirmed using analysis of variance or multiple (ANOVA).
Results
To determine any effects on DPSC phenotypes, vascular endothelial growth factor
(VEGF) was administered in 96-well assays (Figure 1). These results demonstrated that the
majority of DPSC isolates were not significantly affected by VEGF administration, p>0.05.
However, two DPSC isolates (dpsc-3882, dpsc-5653) had significant measurable decreases in
proliferation under VEGF administration, p=0.038 and p=0.041 respectively. In addition, dpsc3882 and dpsc-5653 were both categorized as having rapid doubling times or rDT.
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rDT

iDT

Growth (absorbance 630 nm)

p<0.05

sDT
p>0.05

*
*

Figure 1. Effects of VEGF administration on DPSC growth. Administration of VEGF at 10
ng/mL had a significant effect on two rapidly dividing (rDT) DPSC isolates, dpsc-3882 and
dpsc-5653 – which were significantly lower than the negative controls (p=0.038 and p=0.041,
respectively). No other measurable effects were noted among the intermediate (iDT) or slow
(sDT) DPSC isolates.

To evaluate if the observed changes in proliferation and cellular growth correlated with
any changes to other DPSC phenotypes, cellular viability was also measured under VEGF
administration (Figure 2). Although no significant changes to viability were noted among the
iDT or sDT DPSC isolates under VEGF administration, all three of the rDT DPSC isolates
demonstrated significant measurable increases to viability over the 72 hour time course, p<0.05.
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p>0.05

sDT

iDT
*
*

rDT

*

Cellular viability
Figure 2. Effects of VEGF administration on DPSC viability. Administration of VEGF at 10
ng/mL had no significant effects on the intermediate (iDT) or slow (sDT) DPSC isolates, p>0.05.
However, all three of the rapidly dividing or rDT DPSC isolates, dpsc-3882, dpsc-5653, dpsc7089 exhibited increased viability (p=0.018, p=0.011, p=0.122, respectively).

To determine if any of the changes to cellular growth or viability induced by VEGF
administration among the DPSC isolates were associated with changes to DPSC biomarkers for
osteoblastic differentiation, RT-PCR screening of RNA was performed (Figure 3). In brief,
primers specific for alkaline phosphatase (ALP) and dentin sialophosphoprotein (DSPP) were
used to screen for mRNA expression of these biomarkers. These results demonstrated that VEGF
administration was sufficient to induce mRNA expression of ALP in two DPSC isolates (dpsc3882, dpsc-5653). In addition, VEGF administration was also sufficient to induce DSPP mRNA
expression in one DPSC isolate (dpsc-3882).
14

rDT

iDT

sDT

Figure 3. DPSC osteogenic mRNA biomarker induction following VEGF treatment. VEGF
administration (10 ng/mL) was sufficient to induce mRNA expression of alkaline phosphatase
(ALP) in two rDT DPSC isolates (dpsc-3882, dpsc-5653) and dentin sialophosphoprotein
(DSPP) mRNA expression in dpsc3882. Expression of these mRNA biomarkers were not evident
in any of the other DPSC isolates.

Finally, an evaluation of the MSC biomarkers for each DPSC isolate was performed to
determine if there were any associations with VEGF responsiveness (Figure 4). This analysis
revealed that MSC biomarkers Sox-2, Oct-4 and NANOG were differentially expressed by the
DPSC isolates (Fig 4A). For example, the rDT DPSC isolates each had a distinct expression
profile (dps-3882: Oct-4, NANOG; dpsc-5653: Sox-2, NANOG; dpsc-7089: Sox-2, Oct-4,
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NANOG). In contrast, none of the iDT DPSC isolates expressed Oct-4, while none of sDT
expressed either Sox-2 or Oct-4.
When combined with the results of VEGF assay, these data demonstrated that only the
rDT DPSC isolates that expressed a combination of NANOG with either Oct-4 or Sox-2 (but not
both) were responsive to VEGF administration (Fig. 4B). More specifically, the rDT DPSC
isolate expressing a combination of Oct-4 and NANOG exhibited the most robust VEGF
response, producing both ALP and DSPP (dpsc-3882). The rDT DPSC isolate expressing the
combination of Sox-2 and NANOG exhibited some response to VEGF, producing ALP but not
DSPP (dpsc-5653). However, the rDT isolate that expressed all three MSC biomarkers (Sox-2,
Oct-4, NANOG) did not exhibit an osteogenic response to VEGF administration – similar to the
negative response of the iDT DPSC isolates (Sox-2, NANOG) and sDT DPSC isolates (NANOG
only).
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dpsc-3882
dpsc-5653
dpsc-7089
dpsc-8124
dpsc-17322
dpsc-11418
dpsc-11750
dpsc-11836

Sox-2
Oct-4
NANOG

rDT
rDT
rDT
iDT
iDT
sDT
sDT
sDT

GAPDH
A

rDT

ALP

Nano

rDT

ALP

Oct-4

Nano

rDT

Oct-4

Nano

iDT

Oct-4

Oct-4

Nano

sDT

Oct-4

Oct-4

Nano

Sox-2

Oct-4

Sox-2

Oct-4

Sox-2

Sox-2

Nano

sDT

DSPP

B

Figure 4. MSC mRNA biomarker analysis of DPSC isolates. Osteogenic VEGF response was
observed in DPSC isolates expressing NANOG in combination with either Oct-4 (dpsc-3882) or
Sox-2 (dpsc-5653) but not both (dpsc-7089). No osteogenic VEGF response was noted among
the iDT (Sox-2, NANOG) or sDT (NANOG) DPSC isolates.

Discussion
Research that has evaluated DPSC differentiation has demonstrated the potential to form
many cell types, including neural, osteogenic, and vascular precursors using cytokines and
growth factors, such as vascular endothelial growth factor [11,12]. However, the phenotypic and
cellular effects of VEGF on various lineages of multipotent DPSCs remains relatively unknown,
therefore this study sought to evaluate these effects on several DPSC isolates with distinct
markers of pluripotency[14-16]. The results of this study demonstrated that VEGF has distinct
and specific effects on DPSC phenotypes, although these were not observed uniformly among all
DPSC isolates.
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For example, cellular growth and viability were markedly affected by VEGF only among
the rapidly growing (rDT) DPSC isolates, which mirrors similar findings of VEGF effects on
rapidly dividing MSC from other tissues [24-26]. In addition, VEGF appears to induce
osteogenic biomarker expression in a subset of rDT DPSC isolates, a finding that appears to
support observations of VEGF osteogenic effects in other MSCs [27-29]. To understand these
observations more thoroughly, an analysis of MSC biomarker expression and the associations
with osteogenic marker induction may be necessary [23,30,31].
New evidence has suggested that MSC biomarker expression in DPSCs may determine,
in part, their differentiation potential and responsiveness to external stimuli [32-34]. The results
of this study support these findings, with observations that rapidly dividing DPSC isolates
expressing NANOG in combination with either Sox-2 or Oct-4 were responsive to VEGF
administration. This research may also provide a potential explanation for the observation that
DPSC expression of Oct-4, Sox-2 and NANOG were not responsive to VEGF administration,
noting that “stemness” and pluripotency are correlated with MSC biomarker expression and that
DPSC expression of more MSC biomarkers may indicate more than one stimulus or induction
factor may be needed to facilitate differentiation [35,36].
Conclusions
The results of these data suggest that VEGF administration may be sufficient to induce
partial differentiation of DPSC isolates, although this may be dependent upon the MSC
biomarker expression of the DPSCs. In addition, the phenotypic changes to these DPSC isolates
(decreased growth, increased viability) support these observations and may preliminary data to
further research into the potential for osteogenic differential of DPSC. This may contribute to the
overall, long-term goals of DPSC use for tissue regeneration and bioengineering.
18

Acknowledgements
Dr. Kingsley and Dr. Forgues would like to thank the Department of Advanced
Education in Orthodontics and Dentofacial Orthopedics at the University of Nevada, Las Vegas,
School of Dental Medicine for research funds to complete this pilot study.
Ethics
The authors declare there are no conflicts of interest and no ethical issues to declare

19

References
1. Ferro F, Spelat R, Baheney CS. ;Dental pulp stem cell (DPSC) isolation, characterization, and
differentiation. (2014) Methods Mol Biol.;1210:91-115.
2. Gronthos S, Arthur A, Bartold PM, Shi S. (2011) A method to isolate and culture expand
human dental pulp stem cells.; Methods Mol Biol. 698:107-21.
3. Collart-Dutilleul PY, Chaubron F, De Vos J, Cuisinier FJ. (2015) Allogenic banking of dental
pulp stem cells for innovative therapeutics; World J Stem Cells. 7(7):1010-21.
4. Kabir R, Gupta M, Aggarwal A, Sharma D, Sarin A, Kola MZ. (2014) Imperative role of
dental pulp stem cells in regenerative therapies: a systematic review.; Niger J Surg. 20(1):1-8.
5. Aurrekoetxea M, Garcia-Gallastegui P, Irastorza I, Luzuriaga J, Uribe-Etxebarria V, Unda F,
Ibarretxe G. (2015) Dental pulp stem cells as a multifaceted tool for bioengineering and the
regeneration of craniomaxillofacial tissues. Front Physiol. 6:289.
6. Masthan KMK, Sankari SL, Babu NA, Gopalakrishnan T. (2013) Mystery Inside the Tooth:
The Dental Pulp Stem Cells. Journal of Clinical and Diagnostic Research : JCDR.
2013;7(5):945-947.
7. Isobe Y, Koyama N, Nakao K, Osawa K, Ikeno M, Yamanaka S, Okubo Y, Fujimura K,
Bessho K. (2016) Comparison of human mesenchymal stem cells derived from bone marrow,
synovial fluid, adult dental pulp, and exfoliated deciduous tooth pulp. Int J Oral Maxillofac Surg.
45(1):124-31.
8. Hernández-Monjaraz B, Santiago-Osorio E, Monroy-García A, Ledesma-Martínez E,
Mendoza-Núñez VM. (2018) Mesenchymal Stem Cells of Dental Origin for Inducing Tissue
Regeneration in Periodontitis: A Mini-Review. Int J Mol Sci. 19(4). pii: E944.

20

9. Gonmanee T, Thonabulsombat C, Vongsavan K, Sritanaudomchai H. (2018) Differentiation of
stem cells from human deciduous and permanent teeth into spiral ganglion neuron-like cells.
Arch Oral Biol. 88:34-41.
10. Kim BC, Bae H, Kwon IK, Lee EJ, Park JH, Khademhosseini A, Hwang YS. (2012)
Osteoblastic/cementoblastic and neural differentiation of dental stem cells and their applications
to tissue engineering and regenerative medicine. Tissue Eng Part B Rev. 18(3):235-44.
11. Zhang, Z., Nör, F., Oh, M., Cucco, C., Shi, S., & Nör, J. E. (2016). Wnt/β-Catenin Signaling
Determines the Vasculogenic Fate of Postnatal Mesenchymal Stem Cells. Stem Cells.
https://doi.org/10.1002/stem.2334
12. Zhang W, Walboomers XF, Van Kuppevelt TH, Daamen WF, Van Damme PA, Bian Z,
Jansen JA.(2008) In vivo evaluation of human dental pulp stem cells differentiated towards
multiple lineages. J Tissue Eng Regen Med. 2(2-3):117-25.
13. Kanafi MM, Ramesh A, Gupta PK, Bhonde RR. (2013) Influence of hypoxia, high glucose,
and low serum on the growth kinetics of mesenchymal stem cells from deciduous and permanent
teeth. Cells Tissues Organs. 2013;198(3):198-208.
14. D' Alimonte I, Nargi E, Mastrangelo F, Falco G, Lanuti P, Marchisio M, Miscia S, Robuffo I,
Capogreco M, Buccella S, Caputi S, Caciagli F, Tetè S, Ciccarelli R. (2011) Vascular endothelial
growth factor enhances in vitro proliferation and osteogenic differentiation of human dental pulp
stem cells. J Biol Regul Homeost Agents. 25(1):57-69.
15. Janebodin K, Zeng Y, Buranaphatthana W, Ieronimakis N, Reyes M. (2013) VEGFR2dependent angiogenic capacity of pericyte-like dental pulp stem cells. J Dent Res. 92(6):524-31.

21

16. Silva GO, Zhang Z, Cucco C, Oh M, Camargo CHR, Nör JE. (2017) Lipoprotein Receptorrelated Protein 6 Signaling is Necessary for Vasculogenic Differentiation of Human Dental Pulp
Stem Cells. J Endod. 43(9S):S25-S30.
17. Aksel H, Huang GT. (2017) Combined Effects of Vascular Endothelial Growth Factor and
Bone Morphogenetic Protein 2 on Odonto/Osteogenic Differentiation of Human Dental Pulp
Stem Cells In Vitro. J Endod. 43(6):930-935.
18. Yang Y, Zhao Y, Liu X, Chen Y, Liu P, Zhao L. (2017) Effect of SOX2 on odontoblast
differentiation of dental pulp stem cells. Mol Med Rep. 16(6):9659-9663.
19. Alraies A, Alaidaroos NY, Waddington RJ, Moseley R, Sloan AJ. (2017) Variation in human
dental pulp stem cell ageing profiles reflect contrasting proliferative and regenerative
capabilities. BMC Cell Biol. 18(1):12.
20. Ferro F, Spelat R, D'Aurizio F, Puppato E, Pandolfi M, Beltrami AP, Cesselli D, Falini G,
Beltrami CA, Curcio F. (2012) Dental pulp stem cells differentiation reveals new insights in
Oct4A dynamics. PLoS One. 7(7):e41774.
21. Martens W, Wolfs E, Struys T, Politis C, Bronckaers A, Lambrichts I. (2012) Expression
pattern of basal markers in human dental pulp stem cells and tissue. Cells Tissues Organs.
196(6):490-500.
22. Xiao L, Kumazawa Y, Okamura H. (2014) Cell death, cavitation and spontaneous multidifferentiation of dental pulp stem cells-derived spheroids in vitro: a journey to survival and
organogenesis. Biol Cell. 106(12):405-19.
23. Bakkar M, Liu Y, Fang D, Stegen C, Su X, Ramamoorthi M, Lin LC, Kawasaki T, Makhoul
N, Pham H, Sumita Y, Tran SD. (2017) A Simplified and Systematic Method to Isolate, Culture,

22

and Characterize Multiple Types of Human Dental Stem Cells from a Single Tooth. Methods
Mol Biol. 1553:191-207.
24. Chen L, Xia W, Hou M. (2018) Mesenchymal stem cells attenuate doxorubicin‑induced
cellular senescence through the VEGF/Notch/TGF‑β signaling pathway in H9c2 cardiomyocytes.
Int J Mol Med. 42(1):674-684.
25. Healy ME, Bergin R, Mahon BP, English K. (2015) Mesenchymal stromal cells protect
against caspase 3-mediated apoptosis of CD19(+) peripheral B cells through contact-dependent
upregulation of VEGF. Stem Cells Dev. 24(20):2391-402.
26. Yuan L, Wu MJ, Sun HY, Xiong J, Zhang Y, Liu CY, Fu LL, Liu DM, Liu HQ, Mei CL.
(2011) VEGF-modified human embryonic mesenchymal stem cell implantation enhances
protection against cisplatin-induced acute kidney injury. Am J Physiol Renal Physiol.
300(1):F207-18.
27. Zavan B, Ferroni L, Gardin C, Sivolella S, Piattelli A, Mijiritsky E. (2017) Release of VEGF
from Dental Implant Improves Osteogenetic Process: Preliminary In Vitro Tests. Materials
(Basel). 10(9). pii: E1052.
28. Leegwater NC, Bakker AD, Hogervorst JM, Nolte PA, Klein-Nulend J. (2017) Hypothermia
reduces VEGF-165 expression, but not osteogenic differentiation of human adipose stem cells
under hypoxia. PLoS One. 12(2):e0171492.
29. Murakami J, Ishii M, Suehiro F, Ishihata K, Nakamura N, Nishimura M. (2017) Vascular
endothelial growth factor-C induces osteogenic differentiation of human mesenchymal stem cells
through the ERK and RUNX2 pathway. Biochem Biophys Res Commun. 484(3):710-718.

23

30. Bakopoulou A, Apatzidou D, Aggelidou E, Gousopoulou E, Leyhausen G, Volk J, Kritis A,
Koidis P, Geurtsen W. (2017) Isolation and prolonged expansion of oral mesenchymal stem cells
under clinical-grade, GMP-compliant conditions differentially affects "stemness" properties.
Stem Cell Res Ther. 8(1):247.
31. Karamzadeh R, Eslaminejad MB, Aflatoonian R. (2012) Isolation, characterization and
comparative differentiation of human dental pulp stem cells derived from permanent teeth by
using two different methods. J Vis Exp. (69). pii: 4372.
32. Xie H, Dubey N, Shim W, Ramachandra CJA, Min KS, Cao T, Rosa V. (2018) Functional
Odontoblastic-Like Cells Derived from Human iPSCs. J Dent Res. 97(1):77-83.
33. Zhang X, Li H, Sun J, Luo X, Yang H, Xie L, Yang B, Guo W, Tian W. (2017) Cell-derived
micro-environment helps dental pulp stem cells promote dental pulp regeneration. Cell Prolif.
50(5).
34. Xie H, Chua M, Islam I, Bentini R, Cao T, Viana-Gomes JC, Castro Neto AH, Rosa V.
(2017) CVD-grown monolayer graphene induces osteogenic but not odontoblastic differentiation
of dental pulp stem cells. Dent Mater. 33(1):e13-e21.
35. Pisal RV, Suchanek J, Siller R, Soukup T, Hrebikova H, Bezrouk A, Kunke D, Micuda S,
Filip S, Sullivan G, Mokry J. (2018) Directed reprogramming of comprehensively characterized
dental pulp stem cells extracted from natal tooth. Sci Rep. 8(1):6168.
36. Lee SH, Inaba A, Mohindroo N, Ganesh D, Martin CE, Chugal N, Kim RH, Kang MK, Park
NH, Shin KH. (2017) Three-dimensional Sphere-forming Cells Are Unique Multipotent Cell
Population in Dental Pulp Cells. J Endod. 43(8):1302-1308.

24

Chapter 3
Effects of Vascular Endothelial Growth Factor (VEGF) alone and in combination on rapidly
dividing Dental Pulp Stem Cells (DPSC)
This chapter has been submitted for review and publication in the Ecronicon journal and is
presented in the style of that Journal. The complete Citation is:
Forgues C, Kingsley K. Effects of Vascular Endothelial Growth Factor (VEGF) alone and in
combination on rapidly dividing Dental Pulp Stem Cells (DPSC). Ecronicon Journal
Role of Authors:
This work was carried out in collaboration between all authors. Authors Dr. Karl Kingsley and
Dr. Cale Forgues were responsible for project design, funding and manuscript preparation. A

Abstract
Background: Dental pulp stem cells (DPSC) are known to possess many of the properties
of pluripotent stem cells. Many researchers have focused their efforts to refine the range of
growth factors that influence and modulate DPSC growth and differentiation. More specifically,
some evidence has emerged that demonstrated Vascular Endothelial Growth Factor (VEGF) may
be sufficient to enhance odontogenic and angiogenic potential of some DPSC isolates. Based
upon this information, the primary objective of this study was to evaluate whether VEGF
administration or concomitant VEGF and Bone Morphogenic Protein (BMP) administration
induced any measurable effects on DPSCs.
Methods: This study used six (n=6) previously isolated and characterized DPSCs, cells,
which were sorted into rapid doubling time (rDT ~1-2 days, n=3) and intermediate doubling time
(iDT ~4-6 days, n=3). Each DPSC isolate was plated into 96-well assay plates for three days
using media with and without VEGF, BMP-2 alone and in combination. Cellular growth and
viability were measured for comparison.
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Results: Administration of VEGF reduced growth in two of the rDT DPSC isolates (dpsc3882, dpsc-5653), with no effect on the iDT DPSC isolates (dpsc-8124, dpsc-9894, dpsc17322). A corresponding increase in cellular viability was noted among all the rDT DPSC
isolates along with corresponding changes to cellular morphology, with no effect on the iDT
DPSCs. BMP-2 exhibited no effects on either rDT or iDT DPSC isolates. The combination of
VEGF and BMP-2 in combination had similar effects to the administration of VEGF in isolation.
Discussion: These data provide significant preliminary results that clearly demonstrate
significant and pronounced effects of VEGF on at least one subset of rapidly dividing DPSC
isolates. These effects include changes to cellular viability and growth, which are supported by
clear changes to cellular adhesion and morphology. However, these data strongly suggest more
reseach is needed to determine the underlying pathways triggered by VEGF administration in the
cells and the pathophysiologic mechanisms that determine the responsiveness of these DPSC
isolates but not others.

Key words: Dental Pulp Stem Cells (DSPC), Vascular Endothelial Growth Factor (VEGF).

Background
Dental pulp stem cells (DPSC) are known to possess many of the properties of
pluripotent stem cells [1,2]. Recent studies have demonstrated that DPSCs may have therapeutic
potential as multipotent stem cells with the capacity for reprogramming and bioengineering
applications [3,4]. However, the ability to control and transform DPSC into specific lineages
with precision and accuracy remains an elusive and motivating goal [5-7].
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Many researchers have focused their efforts to refine the range of growth factors that
influence and modulate DPSC growth and differentiation [8]. For example, some studies have
demonstrated specific effects of fibroblast growth factor (FGF) as a transforming growth factor
on DPSCs to facilitate odontoblast differentiation and dentin formation [9,10]. Others have
focused attention on vascular endothelial growth factor (VEGF), which may play a critical role
in DPSC regeneration, differentiation and pluripotency [11,12].
More specifically, some evidence has emerged that demonstrated VEGF may be
sufficient to enhance odontogenic and angiogenic potential of some DPSC isolates [13,14]. In
fact, research from this group recently demonstrated VEGF may have the potential to induce
osteogenic phenotypes in some subsets of DPSC – although these effects were not uniform or
consistent and were mainly restricted to the most rapidly dividing DPSCs [15]. Alternatively,
one recent study demonstrated that VEGF administration or temporal “priming” of DPSC with
VEGF may enhance their odontogenic and osteogenic differentiation potential in combination
with other growth factors, such as bone morphogenic protein (BMP) [16].
Based upon this information, the primary objective of this study was to evaluate whether
VEGF administration or concomitant VEGF and BMP administration induced any measurable
effects on DPSCs.
Material and Methods
Protocol approval
This study was approved through the Office for the Protection of Research Subjects
(OPRS) and the Institutional Review Board (IRB) at the University of Nevada, Las Vegas
(UNLV) under protocol OPRS#763012-1 “Retrospective analytsis of dental pulp stem cells
(DPSC) from the UNLV School of Dental Medicine (SDM) pediatric and clinical population.
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The DPSC isolates were originally collected and obtained under OPRS#0907-3148 “Isolation of
Non-Embryonic Stem Cells from Dental Pulp”. Each DPSC isolate was given a unique
identifying number to prevent bias and disallow any patient identifying information from being
disclosed.

DPSC culture
All DPSC isolates were originally cultured for a minimum of ten (10) passages to
ascertain the rate of growth or doubling time (DT). The average time between passaging for each
DPSC isolate was characterized as either rapid doubling time (rDT) between 0-2 days and
intermediate doubling time (iDT) between 4-6 days. All cells were maintained in Roswell Park
Memorial Institute (RPMI) 1640 Medium with the addition of 10% Fetal Bovine Serum (FBS)
and 1% Penicillin-Streptocmycin from Fisher Scientific. Cells were maintained in 25 cm2 tissue
culture flasks at 5% CO2 in humidified tissue culture chambers.

Experimental growth factors
The previous study from this group determined that only rapdily dividing or rDT DPSC
isolates responded to VEGF administration, therefore - to determine any effects on DPSC
isolates, rDT DPSC isolates were plated into 96-well assay plates for three days using media
with and without additional growth factors. An additional set of experiments with intermediate or
iDT DPSC isolates was used for comparison. Vascular Endothelial Growth Factor (VEGF)
obtained from Fisher Scientific (PCH9394) was used at an experimental concentration of 10
ng/mL and Bone Morphogenic Protein (BMP-2) from Fisher Scientific (RP-8638) at a similar
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concentration of 10 ng/mL. Cells were either plated without any growth factor as a negative
control (CTL), with VEGF, BMP-2 or both VEGF and BMP-2 concomitantly.

Proliferation and Viability
Cells were grown for three days in each experimental condition (n=24 wells/plate) and
each experiment was replicated in triplicate. Experimental assays were fixed with 10% buffered
formalin for 24 hours. Following fixation, cells were stained with Gentian Violet and absorbance
(growth) measured using a BioTek 808x 96-well plate reader. Higher absorbance readings
correspond with higher growth measurements and larger cell numbers, as previously described
[17,18]. Viability was measured using the Trypan Blue exclusion assay and a BioRad TC20
automated cell counter, as previously described [19,20]. Cells were imaged at 20X using an
AxioVert inverted microscope from Ziess.

Statistical analysis
As continuous (parametric) data measurements were made using absorbance readings at
630 nm, differences between experimental and control treatments were evaluated using twotailed t-tests. An alpha level of a=0.05 was used to determine statistical significance.
Results
The results of the initial experimental assay using rapidly dividing or rDT DPSC isolates
demonstrated that two DPSC isolates responded to VEGF administration (Figure 1). More
specifically, VEGF administration induced significant, measurable decreases in cellular growth
among dpsc-3882 (-39.1%, p=0.018) and dpsc-5653 (-12.6%, p=0.039) over three days
compared with the negative control – with no measurable differences observed among dpsc-7089
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(-4.3%, p=0.852). In contrast, administration of BMP-2 did not significantly alter cellular growth
among any of the rDT DPSC isolates, including dpsc-3882 (-2.5%, p=0.948), dpsc-5653 (+2.4%,
p=0.823), and dpsc-7089 (-7.2%, p=0.742). However, concomitant administration of VEGF in
combination with BMP-2 appeared to have a more modest effect on rDT DPSC isolates,
reducing growth in dpsc-3882 (-33.3%, p=0.0241), dpsc-5653 (-6.7%, p=0.592), and dpsc-7089
(-5.8%, p=0.691).
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Figure 1. Growth factor effects on rapidly dividing (rDT) DPSC isolates. Administration of
VEGF reduced growth in dpsc-3882 and dpsc-5653 significantly (-39.1%, p=0.018; -12.6%,
p=0.039) with no effect on dpsc-7089 (-4.3%, p=0.852). Administration of BMP-2 alone
exhibited no significant effects on growth in rDT DPSC isolates, although VEGF-BMP-2 in
combination had a modest effect on dpsc-3882 (-33.3%, p=0.0241).

The results of the subsequent experimental assay using intermediate dividing or iDT
DPSC isolates demonstrated no significant or measurable effects on these DPSC isolates (Figure
2). More specifically, the administration of VEGF did not exhibit any significant effect on
cellular growth in any of the iDT DPSC isolates, including dpsc-8124 (-3.3%, p=0.137), dpsc9894 (+1.3%, p=0.539), and dpsc-17322 (+3.1%, p=0.165). The concomitant administration of
VEGF and BMP-2 also had no significant effect on cellular growth in dpsc-8124 (-8.1%,
p=0.0579), dpsc-9894 (-4.2%, p=0.441), and dpsc-17322 (-0.8%, p=0.887). These results were
similar to the observations with the administration of BMP-2 on dpsc-8124 (-3.6%, p=0.189),
dpsc-9894 (+0.5%, p=0.653), and dpsc-17322 (-1.3%, p=0.794).
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Figure 2. Growth factor effects on intermediate dividing (iDT) DPSC isolates. Administration of
VEGF exhibited no significant effect on iDT DPSC growth: dpsc-8124 (-3.3%, p=0.137), dpsc9894 (+1.3%, p=0.539), and dpsc-17322 (+3.1%, p=0.165) – similar to the effects of BMP-2:
dpsc-8124 (-3.6%, p=0.189), dpsc-9894 (+0.5%, p=0.653), dpsc-17322 (-1.3%, p=0.794).
Combined VEGF and BMP-2 also had no significant effects: dpsc-8124 (-8.1%, p=0.0579),
dpsc-9894 (-4.2%, p=0.441), dpsc-17322 (-0.8%, p=0.887).

To evaluate whether any of the observations in cellular growth were associated with any
changes to survival, cellular viability was evaluated under each control and experimental
condition (Figure 3). These data demonstrated an overall higher viability for the iDT DPSC
isolates at baseline: dpsc-8124 (34%), dpsc-9894 (33%), dpsc-17322 (36%) compared with the
rDT DPSC isolates: dpsc-3882 (21%), dpsc-5653 (23%), dpsc-7089 (22%), which was
statistically significant, p=0.0067.
The addition of VEGF significantly increased cellular viability among the rDT DPSC
isolates, such as dpsc-3882 (35%, +61.9%), dpsc-5653 (35%, +52.1%), and dpsc-7089 (32%,
+45.4%), p=0.0081. However, no corresponding increase in viability was observed in any iDT
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DSPC isolate under , including dpsc-8124 (37%, +5.4%), dpsc-9894 (36%, +5.8%), and dpsc17322 (39%, +8.3%), p=0.102.
However, the addition of BMP-2 did not significantly alter cellular viabilty among the
rDT DPSC isolates, inclduing dpsc-3882 (20%, -4.7%), dpsc-5653 (22%, -4.3%), and dpsc-7089
(21%, -4.5%), p=0.287. Similarly, no effects were observed among the iDT DPSC isolates, such
as dpsc-8124 (35%, no change), dpsc-9894 (31%, -8.8%), and dpsc-17322 (33%, -8.3%),
p=0.221.
The concomitant administration of VEGF and BMP-2 exhibited some effects on rDT but
not iDT cellular viability. More specifically, VEGF-BMP-2 significantly increased viability
among the rDT DPSC isolates, dpsc-3882 (35%, +66.7%), dpsc-5653 (33%, +43.4%), and dpsc7089 (31%, +40.9%), p=0.0036. In contrast, viability among the iDT DPSC isolates was not
significantly changed under VEGF-BMP-2 administration, dpsc-8124 (36%, 2.8%), dpsc-9894
(34%, no change), dpsc-17322 (37%, +2.7%), p=0.566
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Figure 3. Growth factor effects on DPSC cellular viability. The addition of VEGF (alone or in
combination) significantly increased viabilty among the rDT DPSC isolates (dpsc-3882, dpsc5653, dpsc-8124) but had no effects on the iDT DPSC isolates (dpsc-8124, dpsc-9894, dpsc17322). No changes in cellular viability were observed with the administration of BMP-2 in
either the rDT or iDT DPSC isolates.

Microscopy was performed to more closely evaluate the effects of VEGF on growth and
viability of the rDT DPSC isolates (Figure 4). This analysis revealed that the increases in cellular
viability and decrease in growth were associated with significant changes to cellular morphology
in both dpsc-3882 (Fig. 1A, Fig. 1D) and dpsc-5653 (Fig. 1B, Fig. 1E). It was also noted that
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significant cell adhesion, cell spreading and increased cellular size was noted – although fewer
overall numbers of cells were present. In addition, dpsc-7089 also contained a smaller proportion
of cells with changes to adhesion, spreading and increased size (Fig. 1C, Fig. 1F). No changes to
cell number, size or shape were noted among the iDT DPSC isolates (data not shown).
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Figure 4. Cellular morphology of rDT DPSC isolates in control and experimental conditions. The
cellular morphology of rDT dpsc-3882 (A), dpsc-5653 (B), and dpsc-7089 (C) was marked
altered by the addition of VEGF (D-F). Although an overall decrease in cell number was
observed in dpsc-3882 and dpsc-5653 (D,E), an overall increase in cell size, cellular adherence
and cell spreading was observed. No changes were observed with BMP-2 (G-I).
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Discussion
The main objective of this study was to evaluate whether VEGF administration or
concomitant VEGF and BMP administration induced any measurable effects on DPSCs. These
results demonstrated that administration of VEGF was sufficient to reduce growth in two of the
rDT DPSC isolates, with no effect on any of the iDT DPSC isolates. Moreover, a corresponding
increase in cellular viability was noted among all the rDT DPSC isolates along with
corresponding changes to cellular morphology, with no effect on the iDT DPSCs. These results
were in stark contrast to the effects of BMP-2, which exhibited no effects on either rDT or iDT
DPSC isolates. In addition, the combination of VEGF and BMP-2 in combination had similar
effects to the administration of VEGF in isolation, which may suggest VEGF may be primarily
responsible for the observed changes to cellular phenotypes.
Although these data strongly suggest that VEGF may alter rDT cellular phenotypes, such
as viability, proliferation and morphology, the limited scope of this study was not sufficient to
allow for the elucidation of specific pathways responsible for these effects. The limited evidence
that exists for MSC has recently suggested that VEGF may act on mesencymal stem cells
through ERK- and FAK-dependent mechanisms that increase cellular migration – although there
is no evidence to suggest these same pathways may be active among the rDT DPSC isolates
[21,22].
The few studies that have explored VEGF in MSC or DPSC have been mainly restricted
to studies of vasculogenic differentiation, an important topic for bioengineering and therapeutic
applications [23, 24]. However, the potential for VEGF to induce other cellular phenotypes and
differentiation into lineages other than angiogenic and endothelial lineages remains an exciting
and potentially revolutionary application for stem cell therapy [25,26].
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Conclusions
These data provide significant preliminary results that clearly demonstrate significant and
pronounced effects of VEGF on at least one subset of rapidly dividing DPSC isolates. These
effects include changes to cellular viability and growth, which are supported by clear changes to
cellular adhesion and morphology. Taken together, these data strongly suggest more reseach is
needed to determine the underlying pathways triggered by VEGF administration in the cells and
the pathophysiologic mechanisms that determine the responsiveness of these DPSC isolates but
not others.
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Chapter 4: Summary and Conclusions
The two studies presented provide further insight into the effects of vascular endothelial
growth factor (VEGF) on the characteristics of pluripotent dental pulp stem cells (DPSC). It was
the hope that the presence of VEGF would induce differentiation in cultured DPSCs showing a
change in their presenting characteristics and intracellular mRNA biomarker expression.
Chapter 2 of this paper delivered the results of a retrospective study that sought to
determine if the presence of VEGF alone with DPSCs would have any effect on their
characteristics. Eight cell lines were cultured for ten rounds to determine their doubling times.
Doubling time (DT) was categorized as rapid or rDT (~2 days), intermediate or iDT (4-6 days),
and slow or sDT (10-12 days). These categories were then used to help analyze the data
collected. The results of this study revealed that two specific rDT isolates (dpsc-3882, dpsc5653) showed a significant measurable change in their growth when VEGF was administered
(p=0.038 and p=0.041). No significant changes in growth were seen with any of the iDT or sDT
isolates. When evaluating viability, the same two rDT isolates showed a statistically significant
change (p=0.018 and p=0.011). Primer screening specific for alkaline phosphatase (ALP) and
dentin sialophosphoprotein (DSPP) revealed rDT isolate dpsc-3882 to be expressing both DSPP
and ALP, and rDT isolate dpsc-5653 to be only expressing ALP mRNA. Lastly, this study found
that only the rDT group expressed a combination of NANOG with either Oct-4 or Sox-2. These
rDT cell lines were the cell lines that showed significant change in both the growth and viability
tests.
Chapter 3 presented the study done on the comparison of DPSC characteristics when
cultured with VEGF alone, bone morphogenic protein-2 (BMP-2) alone, and when cultured with
a combination of both VEGF and BMP-2. The rDT and iDT DPSC isolates were used in this
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study. Growth and viability were studied and measured for comparison. The results showed that
the rDT isolates had significantly decreased growth when only VEGF was present, however,
when BMP-2 and VEGF were administered in combination the effect on growth was more
moderate. No significant affect was seen on growth when just BMP-2 was cultured with rDT
DPSCs. Additionally, no significant change was seen on growth in any of the iDT samples.
When evaluating viability, the addition of VEGF alone was seen to have a statistically significant
effect on rDT isolates and no effect on iDT isolates. BMP-2 also did not alter the viability in
either the rDT or iDT groups. The combination of VEGF and BMP-2 was seen to have the same
significant effect on viability that VEGF alone did in the rDT group. No change was seen in the
iDT combination group. Cellular microscopy from this study noted cell morphology changes in
dpsc-3882 and dpsc-5653 isolates. Cell adhesions, cell spreading and an increased cellular size
was noted.

Based on the findings in each study, both alternative hypotheses can be accepted.

1. Is there an effect on characteristics of the DPSC lines when cultured with VEGF?
Alternative (HA) hypothesis: There will be an effect on the characteristics of the DPSC
isolates when cultured with VEGF

2. Is there an effect on characteristics of the DPSC lines when cultured with VEGF in
combination with BMP-2?
Alternative (HA) hypothesis: There will be an effect on the characteristics of the DPSC
isolates when cultured with VEGF in combination with BMP-2
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Limitations and Recommendations
A significant limitation in the two studies presented is the number of DPSC cell lines
available. Since DPSC collecting is only being done every couple of years, it has not been
possible to maintain numerous cell lines. Funding for additional collection, as well as the
purchase of standard cell lines, would help to expand the breadth of the study and allow for more
standardized study. With the results from this study, different rDT cell lines would allow for
follow-up studies to assist in determining the specific requirements for a reaction to VEGF.
A follow-up study on different concentrations of VEGF and BMP-2 would provide more
insight into the relationship that the two cytokines have on DPSCs. It would ultimately help to
determine whether there is a competitive or noncompetitive interaction that is affecting the
characteristics of DPSCs.
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